SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-14-300663
Filing Date
2014-08-07
Accepted
2014-08-07 16:06:39
Documents
5
Period of Report
2014-07-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 1 d771087d8ka.htm 8-K/A 21948
2 CONSENT d771087dex231.htm EX-23.1 1527
3 AUDITED FINANCIAL STATEMENTS OF PATH LABS, LLC. d771087dex991.htm EX-99.1 168674
4 CONDENSED FINANCIAL STATEMENTS OF PATH LABS, LLC. d771087dex992.htm EX-99.2 94650
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS d771087dex993.htm EX-99.3 175203
  Complete submission text file 0001193125-14-300663.txt   463264
Mailing Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Business Address 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 9419231949
NEOGENOMICS INC (Filer) CIK: 0001077183 (see all company filings)

IRS No.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35756 | Film No.: 141023881
SIC: 8734 Services-Testing Laboratories